Skip to main content

Evidence-Based Supplement Research

Evidence-Based Supplement Research

Acetyl-Carnitine and Increased HDL Cholesterol Levels

Doses used in studies

g/day: 1.5 (median 1.5, IQR 1.5–1.5) — 1 study

Time to effect

Median: 3 months · IQR 3 months–3 months · Range 3 months–3 months — Reported in 1 of 1 study

1 of 1 paper

Acetyl-L-carnitine Slows the Progression from Prefrailty to Frailty in Older Subjects: A Randomized Interventional Clinical Trial.
- 2022-10
- RCT · n = 92
- Current pharmaceutical design 28(38)
- - Giulia Malaguarnera
  - Vito Emanuele Catania
  - Gaetano Bertino
  - Laura Maria Chisari
  - Maria Castorina
  - Claudia Bonfiglio
  - Omar Cauli
  - Michele Malaguarnera
- PubMed: 36043711
- DOI: 10.2174/1381612828666220830092815
4 Insights on
- Increased HDL Cholesterol Levels
- High evidence
- Clinical
ALCAR group vs. placebo group showed a decrease in HDL cholesterol ... p < 0.01
Effect
Harmful
Effect size
Small
Significant
Yes
Dose
1.5 g BID